Searched for
KRISHNA ELLA
We are able to predict pandemic based on changes in virus, other signals: Bharat Biotech founderWhile speaking at India pavilion at Vivatech 2022, Bharat Biotech founder and chairman Krishna Ella said that the company had predicted Zik...
President to confer Padma awards on late Kalyan Singh, Victor Banerjee, 72 othersAmongst the prominent awardees at the second investiture ceremony will be Padma Vibhushan recipients, former Uttar Pradesh chief minister l...
Neglected infectious diseases may be tomorrow's pandemic: Bharat Biotech chief Dr Krishna EllaBharat Biotech's Covaxin is credited to be India's first indigenous COVID-19 vaccine to be approved and administered to a sizeable populati...
Bharat Biotech chairman donates Rs two crore to Tirumala Tirupati Devasthanams run trustThe official further said the devotees requested the TTD to utilise the donation amount for the temple-run pilgrim free meal trust called S...
WHO refutes Bharat Biotech’s chief Krishna Ella claim that Covaxin faced an intensive scrutinyThe WHO said that the Emergency Use Listing (EUL) is "a neutral, technically rigorous and non-political process, with independent regulator...
Bharat Biotech proud of contribution to historic landmark: Dr Krishna Ella on COVID vaccination coverage crossing 100 cr markTerming the achievement as a "true success story of Atmanirbharta", he said that it was a unified effort of the government, vaccine manufac...
Bharat Biotech's Karnataka facility will have capacity to make 4-5 crore doses of Covaxin a month by Aug-end: MinisterKarnataka has so far conducted 1.12 crore inoculations of coronavirus vaccines in the state comprising first and second doses whereas it ha...
65% of vaccines manufactured in Hyderabad, says Bharat Biotech's Krishna EllaKrishna Ella, whose firm developed India's first indigenous vaccine for Covid-19, said 'pandemic vaccines and everything in future will com...
How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
Bharat Biotech's Krishna Ella is a scientist who avoids any shortcutsElla never takes shortcuts and scientists at his foundation do more research work than probably any other institution in the country, say p...
Serum, Bharat Biotech jointly pledge for smooth vaccine roll out"Adar Poonawala and Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture ...
Bharat Biotech achieved a milestone in indigenous vaccinology: Karnataka MinisterI humbly appeal to everyone, not as a Health Minister but as a fellow medical professional, to refrain from unwarranted criticism which dis...
A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of CovaxinThe approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...
People who are infected should also take vaccine: Bharat Biotech ChairmanBharat Biotech Chairman & MD Krishna Ella was speaking in a virtual session on 'Sero surveillance significance in immunogenicity and safety...
Our COVID-19 vaccine is safe, developed on proven technology, says Bharat Biotech ChairmanBharat Biotech has applied to the drug regulator seeking market authorisation for its potential Covid-19 vaccine-Covaxin which is being dev...
Bharat Biotech gets breakthrough in developing Zika vaccineBharat Biotech’s chief managing director Dr Krishna Ella said his company has ‘an early mover advantage’ in developing the Zika vaccine.
- ICICI Ventures, IFC may exit Bharat Biotech; transaction may value company at 1000 crore
Investment banker Avendus has been mandated by ICICI Ventures to find suitors and the initial process has begun, sources in the know said.